Clinical Trial Update: A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating aripiprazole for Bipolar I disorder with a major depressive episode has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED